Wed, 22 May 2019 12:00:00 EDT GLP-1 REceptor Agonists and Real World EvIdeNce Condition: Type 2 Diabetes Interventions: Drug: Long-acting GLP-1RA; Drug: Short-acting GLP-1RA; Drug: Human-based GLP-1RA; Drug: Exendin-based GLP-1RA; Drug: Fixed ratio BI/GLP-1RA combination; Drug: Flexible BI/GLP-1RA combination Sponsors: University of Padova; Azienda Ospedaliera di Padova Active, not recruiting
Wed, 22 May 2019 12:00:00 EDT High Intensity Interval Training in Severe Mental Illness Conditions: Major Depressive Disorder; Bipolar Disorder; Schizophrenia Intervention: Other: High Intensity Interval Training (HIIT) Sponsors: King's College London; National Institute for Health Research, United Kingdom; South London and Maudsley NHS Foundation Trust Not yet recruiting
Wed, 22 May 2019 12:00:00 EDT Prevention Of Primary Foot Ulcers in High-risk Diabetes Patients Conditions: Diabetes Mellitus; Foot Ulcer, Diabetic; Primary Prevention Intervention: Device: 3D printed insoles for normal footware Sponsors: Countess of Chester NHS Foundation Trust; University of Liverpool; Staffordshire University Not yet recruiting
Tue, 21 May 2019 12:00:00 EDT Effect of Whole-body Vibration on TcPO2 Condition: Diabetes Mellitus, Type 2 Intervention: Other: Whole body Vibration exercise Sponsors: Instituto Nacional de Rehabilitacion; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Recruiting
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.
